Atezolizumab (atezo) therapy for locally advanced/metastatic urinary tract carcinoma (mUTC) in patients (pts) with poor performance status (PS): Analysis of the prospective global SAUL study.

التفاصيل البيبلوغرافية
العنوان: Atezolizumab (atezo) therapy for locally advanced/metastatic urinary tract carcinoma (mUTC) in patients (pts) with poor performance status (PS): Analysis of the prospective global SAUL study.
المؤلفون: Voortman, J
المصدر: Voortman , J 2020 , ' Atezolizumab (atezo) therapy for locally advanced/metastatic urinary tract carcinoma (mUTC) in patients (pts) with poor performance status (PS): Analysis of the prospective global SAUL study. ' , ASCO 2020 Virtual Annual Meeting , 01/06/2020 . https://doi.org/10.1200/JCO.2020.38.15_suppl.5035
سنة النشر: 2020
نوع الوثيقة: conference object
اللغة: English
DOI: 10.1200/JCO.2020.38.15_suppl.5035
الاتاحة: https://research.vumc.nl/en/publications/d5a561d2-da51-4065-ba25-0af28a6d2458
https://doi.org/10.1200/JCO.2020.38.15_suppl.5035
Rights: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.46EF06EE
قاعدة البيانات: BASE